Thermosome
Thermosome is a Healthcare & Life Sciences startup based in Germany, most recent round Seed, 3 tracked investors.
About Thermosome
Based in Germany, Thermosome is a startup founded in 2014. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Thermosome is a biotech company developing thermosensitive liposomal drug formulations to achieve targeted tumor delivery and immune stimulation; its lead candidate THE001 (DPPG2-TSL-DOX) is a thermosensitive liposomal formulation of doxorubicin being developed for locally advanced soft tissue sarcoma in combination with regional hyperthermia.
Explore Thermosome's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.